Hologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Hologic (HOLX) announced that its Affirm Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate ...

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, ...

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape characterized ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

Hologic Inc. closed 22.70% short of its 52-week high of $84.67, which the company reached on August 9th.

Minicarm.com: Your Go-To Source for Hologic Fluoroscan Mini C-Arm Sales, Parts & Service HAUPPAUGE, NEW YORK / ACCESS Newswire / February 4, 2025 / Hologic has officially announced the End-of-Sale and ...

Zacks Investment Research Image Source: Zacks Investment Research In the last four quarters, Hologic surpassed the consensus mark three times and missed once, the average surprise being 3.07%.